Does Dr. VIJAY ABHYANKAR have financial conflicts of interest?

Dr. VIJAY ABHYANKAR (M.D.) has received a total of $137 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $137 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. VIJAY ABHYANKAR?

According to CMS Open Payments data, Dr. VIJAY ABHYANKAR received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($41), ASTRAZENECA PHARMACEUTICALS ($29), and NOVO NORDISK ($18).

Does Dr. VIJAY ABHYANKAR receive research grants or speaking fees?

Dr. VIJAY ABHYANKAR has received $137 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. VIJAY ABHYANKAR

M.D.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: BEL AIR, MD 21014

NPI Number: 1225033806

LIFETIME INDUSTRY VALUE

$137

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABHYANKAR is a verified Internal Medicine practitioner based in BEL AIR, MD.

Between 2021 and 2024, Dr. ABHYANKAR had an overall industry promotional and research financial footprint of $137 as recorded in the federal CMS Open Payments database.

$137 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABHYANKAR's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $41 (representing 29.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$41

29.9%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$29

21.3%

NOVO NORDISK

Rank 3

$18

13.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.